ITPR2 as a susceptibility gene in sporadic amyotrophic lateral sclerosis: a genome-wide association study

Lancet Neurology

Volumn 6, Issue 10, 2007, Pages 869-877

  van Es, Michael A ^a   Van Vught, Paul W ^a   Blauw, Hylke M ^a   Franke, Lude ^b   Saris, Christiaan G ^a   Andersen, Peter M ^c   Van Den Bosch, Ludo ^d   de Jong, Sonja W ^a   van 't Slot, Ruben ^b   Birve, Anna ^c   Lemmens, Robin ^d   de Jong, Vianney ^e   Baas, Frank ^e   Schelhaas, Helenius J ^f   Sleegers, Kristel ^g   Van Broeckhoven, Christine ^g   Wokke, John HJ ^a   Wijmenga, Cisca ^b,h   Robberecht, Wim ^d   Veldink, Jan H ^a   Ophoff, Roel A ^a,i   van den Berg, Leonard H ^a   more..

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^d UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^e ACADEMIC MEDICAL CENTER   (Netherlands)

^f RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^g DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^h UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

ⁱ UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INOSITOL 1,4,5 TRISPHOSPHATE RECEPTOR;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; BELGIUM; BIOCHIP; BLOOD ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE; GENE EXPRESSION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOME ANALYSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SWEDEN;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AMYOTROPHIC LATERAL SCLEROSIS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOME, HUMAN; HUMANS; INOSITOL 1,4,5-TRISPHOSPHATE RECEPTORS; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 34548646702     PISSN: 14744422     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1474-4422(07)70222-3     Document Type: Article

References (49)

1. Cleveland D., and Rothstein J. From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS. Nat Rev Neurosci 2 (2001) 806-819
2. Mitchell J., and Borasio G. Amyotrophic lateral sclerosis. Lancet 369 (2007) 2031-2041
3. Rowland L., and Shneider N. Amyotrophic lateral sclerosis. N Engl J Med 344 (2001) 1688-1700
4. Lacomblez L., Bensimon G., Leigh P., Guillet P., and Meininger V. Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis/Riluzole Study Group II. Lancet 347 (1996) 1425-1431
5. Rosen D., Siddique T., Patterson D., et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362 (1993) 59-62
6. Greenway M., Andersen P., Russ C., et al. ANG mutations segregate with familial and 'sporadic' amyotrophic lateral sclerosis. Nat Genet 38 (2006) 411-413
7. Nishimura A., Mitne-Neto M., Silva H., et al. A mutation in the vesicle-trafficking protein VAPB causes late-onset spinal muscular atrophy and amyotrophic lateral sclerosis. Am J Hum Genet 75 (2004) 822-831
8. Hardiman O., and Greenway M. The complex genetics of amyotrophic lateral sclerosis. Lancet Neurol 6 (2007) 291-292
9. Simpson C., and Al-Chalabi A. Amyotrophic lateral sclerosis as a complex genetic disease. Biochim Biophys Acta 1762 (2006) 973-985
10. Veldink J., Van den Berg L., and Wokke J. The future of motor neuron disease: the challenge is in the genes. J Neurol 251 (2004) 491-500
11. Graham A., Macdonald A., and Hawkes C. British motor neuron disease twin study. J Neurol Neurosurg Psychiatry 62 (1997) 562-569
12. Sathasivam S., Ince P., and Shaw P. Apoptosis in amyotrophic lateral sclerosis: a review of the evidence. Neuropathol Appl Neurobiol 27 (2001) 257-274
13. Van Den Bosch L., Van Damme P., Bogaert E., and Robberecht W. The role of excitotoxicity in the pathogenesis of amyotrophic lateral sclerosis. Biochim Biophys Acta 1762 (2006) 1068-1082
14. Oosthuyse B., et al. Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration. Nat Genet 28 (2001) 131-138
15. Goodall E., Greenway M., van M., I, Carroll C., Hardiman O., and Morrison K. Association of the H63D polymorphism in the hemochromatosis gene with sporadic ALS. Neurology 65 (2005) 934-937
16. Kasperaviciute D., Weale M., Shianna K., et al. Large-scale pathways-based association study in amyotrophic lateral sclerosis. Brain 130 (2007) 2292-2301
17. Lambrechts D., Storkebaum E., Morimoto M., et al. VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death. Nat Genet 34 (2003) 383-394
18. Saeed M., Siddique N., Hung W., et al. Paraoxonase cluster polymorphisms are associated with sporadic ALS. Neurology 67 (2006) 771-776
19. Sutedja N., Sinke R., Van Vught P., et al. The association between H63D mutations in HFE and amyotrophic lateral sclerosis in a Dutch population. Arch Neurol 64 (2007) 63-67
20. Veldink J., Kalmijn S., Van der Hout A., et al. SMN genotypes producing less SMN protein increase susceptibility to and severity of sporadic ALS. Neurology 65 (2005) 820-825
21. Davey S., Ebrahim S., Lewis S., Hansell A., Palmer L., and Burton P. Genetic epidemiology and public health: hope, hype, and future prospects. Lancet 366 (2005) 1484-1498
22. Cordell H., and Clayton D. Genetic association studies. Lancet 366 (2005) 1121-1131
23. The Welcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447 (2007) 661-678
24. Easton D., Pooley K., Dunning A., et al. Genome-wide association study identifies novel breast cancer susceptibility loci. Nature 447 (2007) 1087-1093
25. Klein R., Zeiss C., Chew E., et al. Complement factor H polymorphism in age-related macular degeneration. Science 308 (2005) 385-389
26. van Heel D., Franke L., Hunt K., et al. A genome-wide association study for celiac disease identifies risk variants in the region harboring IL2 and IL21. Nat Genet 39 (2007) 827-829
27. The International HapMap Consortium. The International HapMap Project. Nature 426 (2003) 789-796
28. Borovecki F., Lovrecic L., Zhou J., et al. Genome-wide expression profiling of human blood reveals biomarkers for Huntington's disease. Proc Natl Acad Sci U S A 102 (2005) 11023-11028
29. Tang Y., Lu A., Aronow B., and Sharp F. Blood genomic responses differ after stroke, seizures, hypoglycemia, and hypoxia: blood genomic fingerprints of disease. Ann Neurol 50 (2001) 699-707
30. Maes O., Xu S., Yu B., Chertkow H., Wang E., and Schipper H. Transcriptional profiling of Alzheimer blood mononuclear cells by microarray. Neurobiol Aging (2006). published online Sept 18. DOI:10.1016/j.neurobiolaging.2006.08.004
31. Scherzer C., Eklund A., Morse L., et al. Molecular markers of early Parkinson's disease based on gene expression in blood. Proc Natl Acad Sci U S A 104 (2007) 955-960
32. Brooks B. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. J Neurol Sci 124 suppl (1994) 96-107
33. Chao A., Tsay P., Lin S., Shau W., and Chao D. The applications of capture-recapture models to epidemiological data. Stat Med 20 (2001) 3123-3157
34. Hook E., and Regal R. Capture-recapture methods. Lancet 339 (1992) 742
35. Wen S., Tzeng J., Kao J., and Hsiao C. A two-stage design for multiple testing in large-scale association studies. J Hum Genet 51 (2006) 523-532
36. Cronin S., Hardiman O., and Traynor B. Ethnic variation in the incidence of ALS: a systematic review. Neurology 68 (2007) 1002-1007
37. Purcell S., Neale B., Todd-Brown K., et al. PLINK: a toolset for whole-genome association and population based linkage analysis. Am J Hum Genet 81 (2007) 559-575
38. Price A., Patterson N., Plenge R., Weinblatt M., Shadick N., and Reich D. Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet 38 (2006) 904-909
39. Van Vught P., Sutedja N., Veldink J., et al. Lack of association between VEGF polymorphisms and ALS in a Dutch population. Neurology 65 (2005) 1643-1645
40. Schymick J., Scholz S., Fung H., et al. Genome-wide genotyping in amyotrophic lateral sclerosis and neurologically normal controls: first stage analysis and public release of data. Lancet Neurol 6 (2007) 322-328
41. Dunckley T., Huentelman M., Craig D., et al. Whole-genome analysis of sporadic amyotrophic lateral sclerosis. N Engl J Med (2007). published online Aug 1. DOI:10.1056/NEJMoa070174
42. Mikoshiba K. Inositol 1,4,5-trisphosphate IP(3) receptors and their role in neuronal cell function. J Neurochem 97 (2006) 1627-1633
43. Van Den Bosch L., Verhoeven K., De Smedt H., Wuytack F., Missiaen L., and Robberecht W. Calcium handling proteins in isolated spinal motoneurons. Life Sci 65 (1999) 1597-1606
44. Choe C., and Ehrlich B. The inositol 1,4,5-trisphosphate receptor (IP3R) and its regulators: sometimes good and sometimes bad teamwork. Sci STKE 28 (2006) re15
45. Boehning D., Patterson R., and Snyder S. Apoptosis and calcium: new roles for cytochrome c and inositol 1,4,5-trisphosphate. Cell Cycle 3 (2004) 252-254
46. Tantral L., Malathi K., Kohyama S., Silane M., Berenstein A., and Jayaraman T. Intracellular calcium release is required for caspase-3 and -9 activation. Cell Biochem Funct 22 (2004) 35-40
47. Wozniak A., Wang X., Stieren E., Scarbrough S., Elferink C., and Boehning D. Requirement of biphasic calcium release from the endoplasmic reticulum for Fas-mediated apoptosis. J Cell Biol 175 (2006) 709-714
48. Gutstein D., and Marks A. Role of inositol 1,4,5-trisphosphate receptors in regulating apoptotic signaling and heart failure. Heart Vessels Suppl 12 (1997) 53-57
49. Yamamoto-Hino M., Sugiyama T., Hikichi K., et al. Cloning and characterization of human type 2 and type 3 inositol 1,4,5-trisphosphate receptors. Receptors Channels 2 (1994) 9-22